These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10933749)

  • 21. [Investigation on the relationships among blood zinc, copper, insulin and thyroid hormones in non-insulin dependent diabetes mellitus and obesity].
    Chen MD; Lin WH; Lin PY; Wang JJ; Tsou CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Dec; 48(6):431-8. PubMed ID: 1664281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of acarbose on glucose intolerance in patients with non-insulin-dependent diabetes mellitus.
    Noda K; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1997 Aug; 37(2):129-36. PubMed ID: 9279483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
    Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
    Lancet; 2002 Jun; 359(9323):2072-7. PubMed ID: 12086760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification in sucrose tolerance test with acarbose, guargum and their combination in patients with non-insulin dependent diabetes.
    Shah PK; Lakhotia M; Purohit A; Jain SK; Gupta SK; Bhandari P
    J Assoc Physicians India; 1993 Nov; 41(11):703-5. PubMed ID: 8005921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response profile of acarbose in older subjects with type 2 diabetes.
    Mooradian AD; Albert SG; Wittry S; Chehade J; Kim J; Bellrichard B
    Am J Med Sci; 2000 May; 319(5):334-7. PubMed ID: 10830558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH; Wudy A; Eberlein G; Quast C
    Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC; Benítez Pinto W; Raúl Ariza Andraca C; Casarrubias M
    Arch Med Res; 1998; 29(2):137-41. PubMed ID: 9650328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From control of impaired carbohydrate tolerance to primary prevention of atherosclerosis. Encouraging results of the STOP-NIDDM trial].
    Aronov DM; Bubnova MG
    Kardiologiia; 2003; 43(12):82-5. PubMed ID: 15035259
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized controlled trial of acarbose in hepatic encephalopathy.
    Gentile S; Guarino G; Romano M; Alagia IA; Fierro M; Annunziata S; Magliano PL; Gravina AG; Torella R
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):184-91. PubMed ID: 15704053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of GIP in responders to acarbose in obese Type 2(NIDDM) patients.
    Takei I; Miyamoto K; Funae O; Ohashi N; Meguro S; Tokui M; Saruta T
    J Diabetes Complications; 2001; 15(5):245-9. PubMed ID: 11522498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.
    Reaven GM; Lardinois CK; Greenfield MS; Schwartz HC; Vreman HJ
    Diabetes Care; 1990 Aug; 13 Suppl 3():32-6. PubMed ID: 2209341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarbose.
    Rudovich N; Pivovarova O; Bernigau W; Sparwasser A; Tacke C; Murahovshi V; Mertes G; Birkenfeld AL; Bergmann A; Weickert MO; Pfeiffer AF
    Minerva Endocrinol; 2016 Dec; 41(4):456-68. PubMed ID: 27007919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acarbose for prevention of diabetes mellitus. STOP-NIDDM]].
    Windler E
    Internist (Berl); 2003 Apr; 44(4):491-3. PubMed ID: 12914407
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.
    Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T
    Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532
    [No Abstract]   [Full Text] [Related]  

  • 36. Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data.
    Kaiser T; Sawicki PT
    Diabetologia; 2004 Mar; 47(3):575-580. PubMed ID: 14727025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effect of diabetic treatment on examined parameters].
    Zbrońska H; Grzeszczak W; Jendryczko A; Zbroński R; Kuźniewicz R
    Pol Arch Med Wewn; 1995 Sep; 94(3):228-34. PubMed ID: 8596760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acarbose for patients with hypertension and impaired glucose tolerance.
    Rosenthal JH
    JAMA; 2003 Dec; 290(23):3066; author reply 3067-9. PubMed ID: 14679262
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy.
    Zeymer U; Schwarzmaier-D'assie A; Petzinna D; Chiasson JL;
    Eur J Cardiovasc Prev Rehabil; 2004 Oct; 11(5):412-5. PubMed ID: 15616415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus.
    Zargar AH; Shah NA; Masoodi SR; Laway BA; Dar FA; Khan AR; Sofi FA; Wani AI
    Postgrad Med J; 1998 Nov; 74(877):665-8. PubMed ID: 10197198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.